Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Extremophiles ; 21(3): 603-608, 2017 May.
Article in English | MEDLINE | ID: mdl-28331998

ABSTRACT

Reverse gyrase is an enzyme that induces positive supercoiling in closed circular DNA in vitro. It is unique to thermophilic organisms and found without exception in all microorganisms defined as hyperthermophiles, that is, those having optimal growth temperatures of 80 °C and above. Although its in vivo role has not been clearly defined, it has been implicated in stabilizing DNA at high temperatures. Whether or not it is absolutely required for growth at these high temperatures has yet to be fully determined. In a previous study with an organism that has an optimal growth temperature of 85 °C, it was shown that the enzyme is not a prerequisite for life at extreme temperatures as disruption of its gene did not result in a lethal phenotype at the supraoptimal growth temperature of 90 °C. Herein we show that the enzyme is absolutely required for microbial growth at 95 °C, which in this case is a suboptimal growth temperature. Deletion of the gene encoding the reverse gyrase of the model hyperthermophilic archaeon Pyrococcus furiosus, which has an optimal growth temperature of 100 °C, revealed that the gene is required for growth at 95 °C, as well as at 100 °C. The results suggest that a temperature threshold above 90 °C exists, wherein the activity of reverse gyrase is absolutely necessary to maintain a correct DNA twist for any organism growing at such temperature extremes.


Subject(s)
Archaeal Proteins/metabolism , DNA Topoisomerases, Type I/metabolism , Hot Temperature , Pyrococcus furiosus/enzymology , Archaeal Proteins/genetics , Cell Division , DNA Topoisomerases, Type I/genetics , Enzyme Stability , Extreme Environments , Gene Deletion , Pyrococcus furiosus/genetics , Pyrococcus furiosus/physiology
2.
Mol Cell Biol ; 41(11): e0035721, 2021 10 26.
Article in English | MEDLINE | ID: mdl-34460330

ABSTRACT

Estradiol is essential for the development of female sex characteristics and fertility. Postmenopausal women and breast cancer patients have high levels of estradiol. Aromatase catalyzes estradiol synthesis; however, the factors regulating aromatase activity are unknown. We identified a new 22-kDa protein, aromatase interacting partner in breast (AIPB), from the endoplasmic reticulum of human breast tissue. AIPB expression is reduced in tumorigenic breast and further reduced in triple-negative tumors. Like that of aromatase, AIPB expression is induced by nonsteroidal estrogen. We found that AIPB and aromatase interact in nontumorigenic and tumorigenic breast tissues and cells. In tumorigenic cells, conditional AIPB overexpression decreased estradiol, and blocking AIPB availability with an AIPB-binding antibody increased estradiol. Estradiol synthesis is highly increased in AIPB knockdown cells, suggesting that the newly identified AIPB protein is important for aromatase activity and a key modulator of estradiol synthesis. Thus, a change in AIPB protein expression may represent an early event in tumorigenesis and be predictive of an increased risk of developing breast cancer.


Subject(s)
Aromatase/metabolism , Breast Neoplasms/pathology , Breast/metabolism , Estradiol/biosynthesis , Gene Expression Regulation, Neoplastic/genetics , Neoplasm Proteins/metabolism , Amino Acid Sequence/genetics , Cell Line, Tumor , Cell Transformation, Neoplastic/pathology , Endoplasmic Reticulum/metabolism , Female , Humans , MCF-7 Cells , Progesterone/biosynthesis , RNA Interference , RNA, Small Interfering/genetics
SELECTION OF CITATIONS
SEARCH DETAIL